Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020538 (
hypertension
)
170,190
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apparent mineralocorticoid excess syndrome (AME) is an autosomal recessive disorder that results in low renin
hypertension
and other characteristic clinical features. Typical patients present with severe
hypertension
, hypokalemia, and undetectable aldosterone. Most patients also have low birth weight, failure to thrive, and nephrocalcinosis. The 11betahydroxysteroid dehydrogenase type 2 (11betaHSD2) defect is documented by demonstrating a failure to convert cortisol to cortisone. Here, we report a patient with typical phenotypic features of AME who does not carry any of the previously described mutations in the HSD11B2 gene. This female patient from a consanguineous Pakistani family presented at age 9 yr. She had a low birth weight compared with her siblings and presented with
hypertension
(225/120 mm Hg), low plasma renin activity, hypokalemic metabolic alkalosis, suppressed aldosterone, and bilateral nephrocalcinosis. Echocardiogram did not reveal left ventricular hypertrophy, and baseline ophthalmological evaluation did not demonstrate
hypertensive retinopathy
. However, at age 12 yr, she developed mild to moderate
hypertensive retinopathy
. Biochemical analysis showed an elevated urinary cortisol to cortisone metabolites ratio (tetrahydrocortisol and 5alpha-tetrahydrocortisol/tetrahydrocortisone) of 28 (normal, 0.66-2.44). She had a cortisol secretion rate of 0.43 mg/d (normal, 5-25 mg/d). Sequence analysis of the HSD11B2 gene revealed a novel homozygous delta299 mutation in exon 5. In vitro expression in Chinese hamster ovary cells revealed that this mutation resulted in no activity.
...
PMID:In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess. 1512 15
Systemic Sclerosis (SSc) is a connective tissue disease affecting the skin and internal organs. Retinopathy has been described in patients with SSc, but cannot be distinguished from secondary changes due to concomitant
hypertension
. UCD 200 chickens, a well-established animal model for SSc, were used in this study to investigate the posterior ocular segment for manifestations of SSc. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling was applied to detect endothelial cell (EC) apoptosis, a condition previously shown to represent the first step in SSc pathogenesis in humans and to be present in the skin and the involved internal organs of UCD 200 chickens in the acute stage. Our study showed a complete absence of EC apoptosis in the pecten and choroidal vessels of UCD 200 chickens in the acute stage. Ophthalmoscopy, biomicroscopy and histology revealed normal structures of the pecten, retina and choroid in the chronic stage. In summary, we showed that there is no primary involvement of the posterior ocular segment in avian SSc. SSc of UCD 200 chickens closely mimics human SSc, presenting all the clinical, serological and histological disease manifestations seen in the human counterpart. Therefore, our data raise serious doubts about primary posterior ocular involvement in human SSc. However, fundal examinations in patients with SSc may have their justification for assessment of
hypertensive retinopathy
.
...
PMID:Investigations for retinopathy in an avian model for systemic sclerosis. 1518 3
Elevation of plasma VEGF (vascular endothelial growth factor) has been noted in patients with
hypertension
or atherosclerosis. VEGF has been regarded as a marker for endothelial dysfunction. However, the role of VEGF in
hypertension
-induced vascular injury and its relationship with endothelial function have not been studied. This study included 20 untreated hypertensive men with grade 1 or 2
hypertensive retinopathy
, 10 untreated hypertensive men without
hypertensive retinopathy
and 10 healthy controls. None of the hypertensive patients had diabetes, renal impairment or overt vascular diseases. Plasma VEGF and adhesion molecules were measured using ELISAs. Endothelial function was measured by FMD (flow-mediated vasodilation) of the brachial artery. Plasma levels of VEGF, excluding adhesion molecules, were significantly higher in hypertensive patients with retinopathy when compared with patients without retinopathy (152.4+/-80.8 pg/ml versus 104.7+/-27.2 pg/ml, P = 0.035) or controls (152.4+/-80.8 pg/ml versus 98.9+/-23.7 pg/ml, P = 0.025). Levels of FMD were significantly lower in hypertensive patients than controls, but there were no significant differences between patients with or without retinopathy. Degrees of FMD were inversely correlated with VEGF levels (r = -0.351, P = 0.031). Elevation of plasma VEGF was associated with
hypertensive retinopathy
. Plasma VEGF could be used as a marker of early vascular damage induced by
hypertension
.
...
PMID:Plasma vascular endothelial growth factor as a marker for early vascular damage in hypertension. 1574 Apr 59
Hypertension
is associated with increased cardiovascular risk, leading to systemic end-organ damage, including retinopathy. However, the recent European Society of
Hypertension
-European Society of Cardiology and World Health Organization-International Society of
Hypertension
2003 guidelines propose new prognostic indications for the classification of
hypertensive retinopathy
. In particular, grades I and II are no longer included among signs of end-organ damage, and only grades III and IV are retained as associated clinical conditions for the stratification of global cardiovascular risk. This review article will focus on the wider implications of clinical markers of microvascular damage in the retina, with specific reference to
hypertension
and end-organ damage. Early recognition of retinal changes remains an important step in the risk stratification of hypertensive patients.
...
PMID:Hypertensive retinopathy: there's more than meets the eye. 1577 67
The association between homocysteine and sustained
hypertension
(HT) has been studied. The aim of this study was to assess homocysteine levels in white coat hypertension (WCH) as an indicator of increased risk in the development of cardiovascular diseases. WCH was defined as clinical
hypertension
and a daytime ambulatory blood pressure of < 135/85 mmHg. Plasma levels of homocysteine were determined in patients with WCH,
hypertension
, and normotension (NT). The study group included 100 subjects, 33 with WCH (16 males, 17 females) aged 49.1 +/- 1.9; 35 sustained hypertensives (17 males,18 females) aged 48.5 +/- 1.7 and 32 normotensive control subjects (15 males, 17 females) aged 48.8 +/- 2.2. The subjects were matched for age, gender, and body mass index. Patients with a smoking habit, dyslipidemia, or diabetes mellitus were not included in the study. Homocysteine levels were analyzed by ELISA. Plasma homocysteine levels were significantly higher in the WCH group compared to the controls (12.32 +/- 1.07 versus 5.35 +/- 1.38 micromol/L; P < 0.001) and the WCH group had significantly lower homocysteine values than the hypertensives (19.03 +/- 0.76 micromol/L P < 0.001). Total cholesterol and tri-glycerides were not different among the groups. There were no statistically significant differences in urinary albumin excretion (UAE) or creatinine clearance between the three groups.
Hypertensive retinopathy
was observed in the WCH group, but was less severe and less frequent compared to HTs. LVMI was greater in the WCH group compared to the NTs, but significantly less than HTs. The data demonstrate that WCH is associated with high levels of homocysteine. The increase in homocysteine level in WCH is not as high as in SHT. Since an elevated plasma homocysteine level is a strong risk factor for coronary artery disease and there was target organ damage in our WCH group, we conclude that WCH should not be considered to be an innocent trait.
...
PMID:Hyperhomocysteinemia: an additional risk factor in white coat hypertension. 1587 8
The occurrence of urinary bladder paragangliomas is rare. A 12-year-old Chinese girl who presented with history of blurring of vision was found to have grade IV
hypertensive retinopathy
. Investigations revealed a phaeochromocytoma on the posterior wall of the urinary bladder. A partial cystectomy with right ureter reimplantation was undertaken and her
hypertension
was promptly controlled. The diagnosis and management of this rare tumour is discussed.
...
PMID:Phaeochromocytoma of the urinary bladder. 1596 47
Atherosclerotic renal artery stenosis (ARAS) is a significant cause of end stage renal dysfunction (ESRD) among the elderly. Although early detection of ARAS and induction of adequate treatment could reduce the incidence of ESRD, there have been few reports about parameters predictive of ARAS among Japanese. In this study, we investigated the clinical indicators that predict ARAS among Japanese with risk factors of atherosclerosis (> 40 years of age plus
hypertension
, dyslipidemia or diabetes mellitus). After eliminating the patients who had already been diagnosed with renal artery stenosis, 202 patients were enrolled. The renal arteries of all 202 patients were evaluated by magnetic resonance arteriography (MRA), and the stenoses with > 50% reduction in diameter at the ostium of the renal artery were defined as ARAS. MRA detected ARAS in 42 patients (31 hemilateral and 11 bilateral). Between the patients with and without ARAS there was no significant difference in gender distribution, detection of abdominal vascular bruits or smoking habit. The prevalences of diabetic, hypertensive and cerebrovascular comorbidity were also not significantly different. The mean blood pressure, body mass index and total serum cholesterol values were similar between the two groups. However, age, pulse pressure, serum uric acid, serum creatinine, amount of urinary protein, and coronary artery comorbidity were significantly higher, while estimated creatinine clearance was significantly lower in the patients with ARAS than in those without ARAS. A high prevalence of
hypertensive retinopathy
was also noted among patients with ARAS. Multivariate analysis revealed that older age and renal impairment were independent predictors of ARAS in Japanese patients with atherosclerotic risk factors.
...
PMID:Predictors of undiagnosed renal artery stenosis among Japanese patients with risk factors of atherosclerosis. 1609 67
Hypertensive retinopathy
has long been regarded as a risk indicator for systemic morbidity and mortality. New population-based studies show that
hypertensive retinopathy
signs are strongly associated with blood pressure, but inconsistently associated with cholesterol and other risk factors of atherosclerosis. Mild
hypertensive retinopathy
signs, such as generalized and focal retinal arteriolar narrowing and arteriovenous nicking, are weakly associated with systemic vascular diseases. Moderate
hypertensive retinopathy
signs, such as isolated microaneurysms, haemorrhages and cotton-wool spots, are strongly associated with subclinical cerebrovascular disease and predict incident clinical stroke, congestive heart failure and cardiovascular mortality, independent of blood pressure and other traditional risk factors. These data support the concept that an assessment of retinal vascular changes may provide further information for vascular risk stratification in persons with
hypertension
.
...
PMID:Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. 1614 91
Hypertension
is associated with cardiovascular risk and systemic target organ damage. Retinopathy is considered one of the indicators of target organ damage. This review focuses on recent studies on
hypertensive retinopathy
and their implications for clinical care. Early recognition of
hypertensive retinopathy
signs remains an important step in the risk stratification of hypertensive patients.
...
PMID:Hypertensive retinopathy revisited: some answers, more questions. 1629 49
A prospective, hospital based, clinical study was conducted in hypertensive patients referred to the eye OPD, KMCTH, Sinamangal during a period of three months to find out the incidence of fundus changes. A total of 302 hypertensive patients were included in the study and their fundus changes were evaluated by direct ophthalmoscopy. The age of the patients ranged from 30-70 years and the duration of
hypertension
from 1-25 years. The blood pressure was not controlled in 218 patients (72.18%). More female patients (56.22%) were hypertensive than male (43.78%). But the fundus changes were less in female patients. Caste-wise
hypertension
was more common in Brahmins (38.41%) and fundus changes were also comparatively more. The fundus changes were found in 192 patients (63.57%) and the most common findings were
hypertensive retinopathy
. GrI + GrII combined together (52.31%). The other common fundus finding was BRVO in 11 patients (3.64%). A routine ophthalmoscopic fundus examination to detect the retinal changes in hypertensive patients is recommended.
...
PMID:Incidence of ophthalmoscopic fundus changes in hypertensive patients. 1634 Feb 57
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>